Holen Sie sich die Stockscreener-App
13.60
7.09%
0.90
Ocular Therapeutix Inc Aktie (OCUL) Neueste Nachrichten
Ocular Therapeutix: A High-Stakes Bet On Becoming The New Standard Of Care (NASDAQ:OCUL) - Seeking Alpha
Key deals this week: Ocular Therapeutix, CoreWeave, Air Lease, Cadence and more (AL:NYSE) - Seeking Alpha
Best data tools to analyze Ocular Therapeutix Inc. stockWeekly Market Summary & Target Return Focused Stock Picks - Newser
Is Ocular Therapeutix Inc. a candidate for recovery play2025 Key Lessons & AI Forecasted Entry and Exit Points - Newser
Can Ocular Therapeutix Inc. rally from current levelsEarnings Growth Summary & Growth-Oriented Investment Plans - Newser
Can Ocular Therapeutix Inc. disrupt its industryEarnings Summary Report & Real-Time Buy Zone Alerts - خودرو بانک
Signal strength of Ocular Therapeutix Inc. stock in tech scannersTrade Exit Summary & Weekly High Return Forecasts - Newser
Visual trend scoring systems applied to Ocular Therapeutix Inc.July 2025 Snapshot & Daily Profit Maximizing Tips - Newser
What candlestick patterns are forming on Ocular Therapeutix Inc.Trade Volume Report & Real-Time Buy Zone Alerts - Newser
What to do if you’re stuck in Ocular Therapeutix Inc.2025 Buyback Activity & Long Hold Capital Preservation Tips - Newser
Will Ocular Therapeutix Inc. outperform the market in YEAR2025 Buyback Activity & Real-Time Volume Surge Alerts - خودرو بانک
Ocular Therapeutix Shares Rise on Takeover Speculation - AInvest
Ocular Therapeutix gains amid takeover speculation (update) (OCUL:NASDAQ) - Seeking Alpha
Is Ocular Therapeutix Inc. stock bottoming outExit Point & Intraday High Probability Setup Alerts - Newser
Has Ocular Therapeutix Inc. found a price floorTrade Risk Assessment & Low Volatility Stock Suggestions - Newser
How to build a dashboard for Ocular Therapeutix Inc. stockBuy Signal & High Conviction Buy Zone Alerts - Newser
Is Ocular Therapeutix Inc. stock forming a triangle pattern2025 Volatility Report & Growth Focused Stock Reports - خودرو بانک
Ocular Therapeutix's Unusual Options Activity: A Closer Look - AInvest
How to build a custom watchlist for Ocular Therapeutix Inc.Rate Hike & Fast Momentum Stock Entry Tips - Newser
Ocular Therapeutix CEO Donald Notman sells 1066 shares at $12.43/share on Sept 2, 2023. - AInvest
Acute Respiratory Distress Syndrome Market Forecast and Company Analysis Report 2025-2033 Featuring Ajanta, Akorn, Alembic, Cipla, Indoco Remedies, J&J, Novartis, Ocular Therapeutix, Sun, Teva - GlobeNewswire
How hedge fund analytics apply to Ocular Therapeutix Inc. stockMarket Activity Summary & Fast Exit/Entry Strategy Plans - Newser
What are Ocular Therapeutix Inc.’s earnings expectationsQuarterly Portfolio Report & Fast Gain Swing Alerts - خودرو بانک
Will Ocular Therapeutix Inc. outperform the marketPortfolio Risk Summary & Accurate Trade Setup Notifications - Newser
Technical analysis overview for Ocular Therapeutix Inc. stockJuly 2025 Closing Moves & Smart Swing Trading Alerts - Newser
Ocular Therapeutix Inc. stock retracement – recovery analysis2025 Fundamental Recap & Verified Short-Term Plans - Newser
Ocular Therapeutix Inc. stock trend outlook and recovery pathPortfolio Risk Summary & Low Drawdown Momentum Trade Ideas - Newser
Backtesting results for Ocular Therapeutix Inc. trading strategiesWeekly Profit Recap & Verified Momentum Watchlists - Newser
Is Ocular Therapeutix Inc. stock poised for growthDollar Strength & Reliable Breakout Forecasts - Newser
Chart based analysis of Ocular Therapeutix Inc. trends2025 Market Overview & Risk Managed Trade Strategies - Newser
How to use a screener to detect Ocular Therapeutix Inc. breakouts2025 Trading Recap & Daily Growth Stock Tips - Newser
Ocular Hypertension Pipeline Insights Report DelveInsight | Santen Pharmaceutical, Nicox Ophthalmics, Inc., Allysta Pharmaceuticals, Qlaris Bio, Inc, Ripple Therapeutics, Laboratoires Thea, Ocular T - The Globe and Mail
Ocular Therapeutix stock hits 52-week high at $12.91 - Investing.com
Sector ETF performance correlation with Ocular Therapeutix Inc.July 2025 Macro Moves & Reliable Price Breakout Signals - Newser
Visual analytics tools that track Ocular Therapeutix Inc. performance2025 Growth vs Value & Scalable Portfolio Growth Methods - Newser
Does Ocular Therapeutix Inc. stock benefit from AI growthJuly 2025 Spike Watch & Reliable Breakout Forecasts - خودرو بانک
Historical volatility pattern of Ocular Therapeutix Inc. visualizedWeekly Risk Report & Safe Entry Momentum Tips - Newser
Can Ocular Therapeutix Inc. maintain its current growth rate2025 Dividend Review & Technical Entry and Exit Tips - خودرو بانک
Statistical indicators supporting Ocular Therapeutix Inc.’s strengthQuarterly Earnings Report & High Accuracy Trade Alerts - Newser
How much upside does Ocular Therapeutix Inc. haveJuly 2025 Trade Ideas & Safe Swing Trade Setups - خودرو بانک
EURETINA Innovation Spotlight kickstarts the 2025 Congress - Modern Retina
What are Ocular Therapeutix Inc.’s technical support levelsJuly 2025 Technicals & AI Powered Market Entry Ideas - خودرو بانک
Will Ocular Therapeutix Inc. benefit from macro trends2025 Volatility Report & Weekly High Conviction Trade Ideas - Newser
Is Ocular Therapeutix Inc. currently under institutional pressureEarnings Recap Report & Weekly High Return Stock Opportunities - خودرو بانک
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):